Clinical Trial Update: Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study [Phase 3]

View source ↗

Summary

This update describes a Phase III clinical trial evaluating toripalimab plus lenvatinib and gemcitabine-based chemotherapy as first-line treatment for advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Intrahepatic Cholangiocarcinoma | Phase 3 | Status: RECRUITING